The federal Project Grant award, provided by the U.S. Department of Transportation's Federal Transit Administration under the All Stations Accessibility Program (CFDA 20.533), will fund a study to examine opportunities for realigning tight curved trackage near the Chatham and Orange rail stations operated by NJ Transit. The $2,000,000 award, with a completion date of December 30, 2028, aims to identify cost-effective solutions to increase service speeds, reduce track and wheel wear, and...
The Federal Transit Administration (FTA) awarded a $740,000 Project Grant to the New Jersey Transit Corporation under the Federal Transit Capital Investment Grants program (CFDA 20.500). The grant funds will support a comprehensive transit-oriented development (TOD) planning process for the light rail corridor in the Englewood, Leonia, Palisades Park, and Ridgefield areas of New Jersey. The planning activities will involve data collection, community engagement, corridor and station area...
This $9,698,773 Formula Grant award to the New Jersey Transit Corporation, doing business as NJ Transit, was provided by the U.S. Department of Transportation's Federal Transit Administration under the Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513). The funding will support NJ Transit's operating and mobility management activities to meet the transportation needs of seniors and persons with disabilities across New Jersey. Key activities include the...
The Federal Transit Administration (FTA) awarded a $15,514,798 Formula Grant under the Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513) to the New Jersey Transit Corporation (NJ Transit). The grant funding will support the purchase of gas and electric vehicles equipped with lifts or ramps to enhance mobility management and operating projects for public bodies and private non-profits throughout New Jersey. NJ Transit will provide oversight and technical...
This $290,000 federal Formula Grant award, provided by the U.S. Department of Transportation's Federal Transit Administration through its Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513), will support New Jersey Transit Corporation's efforts to improve air quality and reduce transportation emissions from on-road highway sources in New Jersey. The funding will be used to purchase vehicles, which will help mitigate congestion and improve air quality for...
The New Jersey Transit Corporation was awarded a $1,341,747 Formula Grant by the Federal Transit Administration's Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513). The grant funds will be used to support one mobility management project and ten operating projects for subrecipients across New Jersey. The subrecipients will use the funding to provide transportation services for seniors and individuals with disabilities statewide. Key subrecipients awarded...
The New Jersey Transit Corporation (NJ Transit) was awarded a $1,176,000 Project Grant from the U.S. Department of Transportation Federal Transit Administration (FTA) under the Federal Transit Capital Investment Grants program (CFDA 20.500) to conduct comprehensive transit-oriented development planning for the proposed Route 9 Bus Rapid Transit project in Middlesex and Monmouth Counties, New Jersey. NJ Transit will use $470,000 in FY 2021 Discretionary TOD Pilot funds from the grant along with...
The New Jersey Transit Corporation (NJ Transit) was awarded a $1.13 billion Project Grant from the United States Department of Transportation Federal Transit Administration under the Federal Transit Formula Grants program (CFDA 20.507) on June 3, 2021. The award will support NJ Transit's operating assistance through December 30, 2025. The Federal Transit Formula Grants program makes federal funding available to local and regional authorities for transit capital, operating assistance, and...
This is a Formula Grant award from the U.S. Department of Transportation's Federal Transit Administration (FTA) under the Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513). The $1,096,000 grant awarded to the New Jersey Transit Corporation (NJ Transit) on August 15, 2024 is intended to support the purchase of vehicles to improve air quality and reduce transportation emissions in New Jersey. The grant aims to mitigate congestion and enhance air quality by...
The New Jersey Transit Corporation received a $15.465 million Project Grant award from the Federal Transit Administration's Enhanced Mobility of Seniors and Individuals with Disabilities program (CFDA 20.513) on September 23, 2022. The grant will fund the purchase of 25 accessible passenger vehicles, including 21 gas-powered and 4 electric vehicles, as well as operating expenses and mobility management projects for 29 subrecipients through December 31, 2026. Subrecipients will utilize the...